Scholar Rock to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company, announced its participation in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 5:20 p.m. ET. The event will feature a live webcast accessible through the Investors & Media section of their website. An archived version of the presentation will be available for about 90 days after. Scholar Rock focuses on developing innovative therapies targeting protein growth factors for serious conditions like neuromuscular disorders, cancer, fibrosis, and anemia.

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will present at the 39^th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:20 p.m. ET.

A live webcast of the presentation may be accessed by visiting the Investors & Media section of the Scholar Rock website at http://investors.scholarrock.com. An archived replay of the webcast will be available on the Company’s website for approximately 90 days following the presentation.

About Scholar Rock

Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, fibrosis and anemia. Scholar Rock’s approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path.

Scholar Rock® is a registered trademark of Scholar Rock, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210104005018/en/

FAQ

What is Scholar Rock presenting at the J.P. Morgan Healthcare Conference 2021?

Scholar Rock is presenting at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 5:20 p.m. ET.

How can I access the live webcast of Scholar Rock's presentation?

The live webcast can be accessed on the Investors & Media section of Scholar Rock's website.

Will there be a replay of Scholar Rock's presentation at the conference?

Yes, an archived replay will be available on Scholar Rock's website for approximately 90 days after the presentation.

What diseases does Scholar Rock focus on in their research?

Scholar Rock focuses on serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.

What is the stock symbol for Scholar Rock?

Scholar Rock's stock symbol is SRRK.